Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses-Reference-Cited by-同舟云学术

Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses

Published:2013-06-25 Issue:9 Volume:104 Page:1162-1171
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Qi Lei,Toyoda Hidemi¹,Shankar Vipin¹,Sakurai Naoto¹,Amano Keishirou¹,Kihira Kentaro¹,Iwasa Tadashi¹,Deguchi Takao¹,Hori Hiroki¹,Azuma Eiichi¹,Gabazza Esteban C.²,Komada Yoshihiro¹

Affiliation:

1. Department of Pediatrics and Developmental Science; Graduate School of Medicine; Mie University; Tsu; Japan

2. Department of Immunology; Graduate School of Medicine; Mie University; Tsu; Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12204/fullpdf

Reference53 articles.

1. Advances in the diagnosis and treatment of neuroblastoma;Katzenstein;Curr Opin Oncol,1998

2. Neuroblastoma;Davidoff;Semin Pediatr Surg,2012

3. Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors;Jögi;Ups J Med Sci,2012

4. IGF, IGF receptor and overgrowth syndromes;Bentov;Pediatr Endocrinol Rev,2004

5. The insulin-like growth factor-1 receptor as an onogene;Werner;Arch Physiol Biochem,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions of Butyrylcholinesterase with Neuroblastoma-associated Oncoproteins;Current Enzyme Inhibition;2023-08-08

2. Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibition;Molecular and Clinical Oncology;2022-07-21

3. BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells;Cancers;2022-06-01

4. Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism;Antioxidants;2022-05-06

5. Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs;International Journal of Molecular Sciences;2021-11-28